Prospera Financial Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
560
-7
-1% -$3.94K ﹤0.01% 1234
2026
Q1
$336K Sell
567
-532
-48% -$265K 0.01% 1169
2025
Q4
$535K Sell
1,099
-6
-0.5% -$2.79K 0.01% 902
2025
Q3
$463K Buy
1,105
+4
+0.4% +$1.34K 0.01% 965
2025
Q2
$316K Buy
1,101
+5
+0.5% +$1.49K 0.01% 1082
2025
Q1
$338K Buy
1,096
+7
+0.6% +$2.4K 0.01% 940
2024
Q4
$384K Buy
1,089
+14
+1% +$5.15K 0.01% 831
2024
Q3
$385K Sell
1,075
-2
-0.2% -$676 0.01% 823
2024
Q2
$343K Sell
1,077
-10
-0.9% -$2.65K 0.01% 863
2024
Q1
$250K Sell
1,087
-2
-0.2% -$451 0.01% 968
2023
Q4
$239K Sell
1,089
-63
-5% -$14.5K 0.01% 930
2023
Q3
$260K Sell
1,152
-19
-2% -$4.38K 0.01% 854
2023
Q2
$258K Buy
+1,171
New +$259K 0.01% 867
2022
Q2
Sell
-42
Closed -$8K 2568
2022
Q1
$8K Buy
+42
New +$8K ﹤0.01% 2141
2018
Q1
Sell
-1,600
Closed -$240K 465
2017
Q4
$240K Sell
1,600
-550
-26% -$69.9K 0.04% 347
2017
Q3
$263K Buy
2,150
+50
+2% +$6.38K 0.04% 347
2017
Q2
$277K Buy
+2,100
New +$262K 0.04% 326

Other funds holding UTHR

Prospera Financial Services's UTHR Position: Q2 2026 in Review

Prospera Financial Services reduced its United Therapeutics (UTHR) stake by 1.2% in Q2 2026, selling an estimated $3.94K and leaving 560 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

Prospera Financial Services first reported a position in UTHR in Q2 2017 and has held it in 17 quarters since. The position peaked at $535K in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Prospera Financial Services held 560 shares of United Therapeutics worth $303K as of Q2 2026.
  • Prospera Financial Services sold 7 United Therapeutics shares in Q2 2026, an estimated $3.94K.
  • United Therapeutics made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1234 holding.
  • Prospera Financial Services first reported a position in United Therapeutics in Q2 2017 and has held it in 17 quarters since.
  • Prospera Financial Services's United Therapeutics position peaked at $535K in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.